Search results
Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 2 months agoArcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q1 2024 Earnings Call Transcript May 8, 2024...
Q4 2023 Arcturus Therapeutics Holdings Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Singapore Finance· 4 months agoParticipants Neda Safarzadeh; VP of IR, Public Relations, and Marketing; Arcturus Therapeutics Holdings, Inc. Joe Payne; President and CEO; Arcturus Therapeutics Holdings, Inc. Andrew Sassine ...
Arcturus Therapeutics Holdings Inc (ARCT) (Q1 2024) Earnings Call Transcript Highlights: ...
GuruFocus.com via Yahoo Singapore Finance· 2 months agoRevenue: Q1 2024 revenue was $38 million, up from $30.9 million in Q4 2023. Net Loss: Reported a net loss of $26.8 million in Q1 2024, compared to a net loss of $11.7 million in Q4 2023. Earnings ...
Kirin's electric spoon leaps from Ig Nobel infamy to the dinner table
Reuters via Yahoo Singapore Finance· 2 months agoJapanese drinks giant Kirin Holdings will start selling an electrified spoon that researchers claim...
Japan Post Bank Co Ltd's Dividend Analysis
GuruFocus.com via Yahoo Singapore Finance· 3 months agoJapan Post Bank Co Ltd (JPSTF) recently announced a dividend of $50 per share, payable on a date yet to be determined, with the ex-dividend date set for...
Analysis-Japan's back-to-back wage bonanza would open door for BOJ exit
Reuters via Yahoo Singapore Finance· 8 months agoJapan's big employers are set to follow this year's bumper pay hikes with another round in 2024,...
Nikkei parties like it's 1989; scales record high
Reuters via Yahoo Singapore Finance· 5 months agoSINGAPORE (Reuters) -Japanese stocks raced to a record peak on Thursday, breaking levels last seen in 1989 during the halcyon days of the bubble economy,...
Japan panel recommends approval of updated Daiichi Sankyo COVID shot- Kyodo
Reuters via Yahoo Singapore Finance· 7 months agoA Japanese health ministry panel on Monday recommended approval for an updated version of Daiichi Sankyo's COVID-19 vaccine, the Kyodo news agency said. The mRNA-based shot was initially approved ...
